Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
Express News | Exact Sciences CEO Kevin Conroy Buys 19,500 Shares At $51.35 Each, Investing $1M; Now Holds 1.07M Direct Shares, With Total Holdings Reaching 1.41M Shares Plus 683K Options And Restricted Stock Units
Exact Sciences Corporation (EXAS) Rebounded From the Previous Quarter
Exact Sciences Is Maintained at Overweight by Piper Sandler
Exact Sciences Analyst Ratings
Alen Kok : Oh